Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and CAH
NCT02096510Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone sodium succinate in Addison's disease, congenital adrenal hyperplasia (CAH), sponsored by Haukeland University Hospital. Started Mar 2014; status: completed.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
Addison's diseasecongenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT02096510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02096510.